baber/WOPTO huggingface dataset:
Patent AU-695881-B2 (AU)
Title: Method for removing catalyst from an oligomer product
Inventor: NISSFOLK FREDRIK
IPC: C08F4/06
Filed: 1995-06-23
Granted: 1998-08-27
Abstract: Method for removing catalyst from an olefinic oligomerization product, comprising the steps of oligomerizing one or more olefins in presence of a BF3 cocatalyst complex, and distilling the oligomerization product while separating vaporized BF3 cocatalyst complex, said distillation step comprising, simultaneously to said separation of BF3 cocatalyst complex, a separation of vaporized unreacted monomer from a bottom product which becomes substantially free from BF3 cocatalyst complex.
Patent AU-715663-B2 (AU)
Title: Improved medical containers
Inventor: ANDERSSON GUNNAR
IPC: A61J1/05
Filed: 1997-04-23
Granted: 2000-02-10
Abstract: A sealed container opening, intended for fluid communication with a container for storing medical fluids, comprising a tubular sleeve-formed part (22, 22A) having a resilient pierceable stopper (24, 24A) inserted in its mouth (21, 21A) and a covering sealing device (10, 10A). The sealed container opening contains the same autoclavable polyolefinic material as the container. All parts of said container opening, exposed to the fluid or fluid handling devices are sterilized in a signal process by means of steam transferred to these parts during its autoclavation. Saddle formed port systems attachable to a flexible container are also disclosed.
Patent AU-739316-B2 (AU)
Title: Flexible power and control cable for high noise environments
Inventor: LAPIDUS STEVEN G
IPC: H01B7/04
Filed: 1999-02-26
Granted: 2001-10-11
Abstract: A flexible power cable includes a plurality of power conductors each having insulation thereon and being arranged to form interstices between adjacent ones of the power conductors. Each of the power conductors includes a plurality of conductor strands. An insulated grounding conductor is provided in each interstice and together with the power conductors define a conductor bundle. An inner jacket surrounds the conductor bundle. A flexible, braided sheath member surrounds the inner jacket and is constructed and arranged to limit transmission and susceptibility to electromagnetic and radio frequency interference. An outer polymeric jacket surrounds the braided sheath member. The insulation of the power conductors and of the grounding conductors is lubricated so that the power conductors and the grounding conductors may move relative to each other and with respect to the inner jacket upon flexing of the cable.
Patent AU-777313-B2 (AU)
Title: Hydrophilic macromolecular compounds
Inventor: HODD KENNETH A
IPC: C08F220/56
Filed: 2000-03-16
Granted: 2004-10-14
Abstract: The invention relates to macromolecular hydrophilic photocrosslinkers having polymeric backbones of substituted ethylene groups carrying photoactive groups. The photocrosslinkers are capable of producing, when being exposed to light of determined wavelengths above 305 nm, radicals which are retained on the macromolecular photocrosslinkers and reacting so as to accomplish a crosslinked network structure. The invention further relates to the preparation of photocrosslinkers, their use in different aqueous systems and their utility in production of medical devices including ophthalmic lenses.
Patent AU-627174-B2 (AU)
Title: Human growth hormone formulation
Inventor: PEARLMAN RODNEY
IPC: A61K9/12
Filed: 1989-03-28
Granted: 1992-08-20
Abstract: Dimer and aggregate formation in hGH formulations liable to exposure to shear surface stresses is inhibited by the inclusion of 0.1 to 5% w/v of a non-ionic surfactant such as polysorbate 80 or poloxamer 188. <IMAGE>   <IMAGE>
Patent AU-673994-B2 (AU)
Title: Modification of vegetable oil with desaturase
Inventor: ALEXANDER WILLIAM LARRY
IPC: A01H5/10
Filed: 1993-03-12
Granted: 1996-12-05
Abstract: Plant seed having yeast delta-9 desaturase gene therein, preferably in association with a suitable promoter and termination sequence. A method for modifying the fatty acid content of seed oil, by transforming seed with yeast delta-9 desaturase.
Patent AU-563430-B2 (AU)
Title: Circuit card edge connector
Inventor: ANDREWS HOWARD WALLACE JR
IPC: H01R13/193
Filed: 1985-01-30
Granted: 1987-07-09
Abstract: A zero insertion force card edge connector (10) incorporates a flexible film circuit (18) providing an interconnection between a mother board (12) and a daughter board (14). Slidable cam means (22) are arranged to drive the flexible film circuitry against a face of the daughter board (14) after insertion and include keying means (40) arranged to register in apertures of the daughter board (14). A cam follower (24) is disposed between the cam means (22) and flexible film circuitry (18) which is inhibited against sliding movement with the cam by cooperating means (94, 34). Cooperating means acting between the cam (22) and follower (24) being adapted on movement of the follower (24) towards the daughter board (14) to effect a double wiping action between contact (10) of the flexible film circuitry (18) and complementary contacts on the daughter board.
Patent AU-714968-B2 (AU)
Title: Neuritin, a neurogene
Inventor: THEILL LARS EYDE
IPC: C07K16/22
Filed: 1997-08-07
Granted: 2000-01-13
Abstract: Disclosed are DNA and amino acid sequences for a novel polypeptide termed Neuritin which is expressed primarily in selected regions of the brain.
Patent AU-759659-B2 (AU)
Title: Coupling sleeve for high-pressure pipe
Inventor: DALMOLEN LAMBERTUS GERRIT
IPC: F16L47/02
Filed: 1999-05-17
Granted: 2003-04-17
Abstract: A coupling sleeve (4) with thermoplastic outer and inner bushes (6,5) and has resistance wires (7) between them. The bushes have teeth which have a steeply slanting tooth flank (23) and a relatively gently slanting tooth flank (24). When the resistance wires are connected to an electricity source, the heat generated melts the coupling sleeve and those of each pipe joint in order to create a welded joint. The bushes are made up of thermosetting material such as vinyl ester or epoxy resin reinforced by carbon fibers or glass fibers. They have a tensile modules greater than 50 GPa. The pipes each comprises of a fluid tight inner casing of thermoplastic material and a reinforced outer casing (12). The inner casings have to be connected in a watertight joint.
Patent AU-673127-B2 (AU)
Title: Wheel chocking system for arresting road vehicles during transportation
Inventor: WINSOR ROBERT B
IPC: B60P3/077
Filed: 1995-11-24
Granted: 1996-10-24
Abstract: A wheel chocking system for restraining road vehicles being transported on a vehicle support surface of a transport vehicle is disclosed. The support surface has a grating disposed in at least a wheel support area where one or more road vehicles are positioned. The grating is formed by a grid of rods to which is secured chock members at desired positions relative to the position of the wheels of the road vehicle positioned over the wheel support area. Each chock has a base with disengageable attachment members in a lower engaging surface thereof to immovably secure the chock to the grating. The chock has an angled face plate which is positioned relative to an outer tread surface of a tire of a wheel to restrain movement thereof. Load transmitting members transfer a load applied to the face plate onto the base member and into the grating secured to the support surface. A lateral restraining member is provided on a side of the face plate and disposed adjacent an inner side wall portion of the tire to prevent lateral shifting of the vehicle positioned on the support surface.
Patent AU-680411-B2 (AU)
Title: Antibodies to alphavbeta3 integrin
Inventor: KIM KYUNG JIN
IPC: A61K47/48
Filed: 1993-03-30
Granted: 1997-07-31
Abstract: PCT No. PCT/US93/02987 Sec. 371 Date Sep. 30, 1994 Sec. 102(e) Date Sep. 30, 1994 PCT Filed Mar. 30, 1993 PCT Pub. No. WO93/20229 PCT Pub. Date Oct. 14, 1993Hybridoma cell line, ATCC HB 11029, which produces murine monoclonal antibody, 10C4.1.3 which specifically binds to alphavbeta3 integrin on human osteoclasts, and is capable of blocking binding of alphavbeta3 integrin to fibrinogen or to vitronectin. The antibody is useful for detecting alphavbeta3 integrin on cells in histological and diagnostic assays, and to treat disease conditions that are characterized by excessive bone resorption.
Patent AU-738431-B2 (AU)
Title: Bioconjugates and delivery of bioactive agents
Inventor: GRISSOM CHARLES B
IPC: A61K48/00
Filed: 1997-08-22
Granted: 2001-09-20
Abstract: The present invention relates to bioconjugates and the delivery of bioactive agents which are preferably targeted for site-specific release in cells, tissues or organs. More particularly, this invention relates to bioconjugates which comprise a bioactive agent and an organocobalt complex. The bioactive agent is covalently bonded directly or indirectly to the cobalt atom of the organocobalt complex. The bioactive agent is released from the bioconjugate by the cleavage of the covalent bond between the bioactive agent and the cobalt atom in the organocobalt complex. The cleavage may occur as a result of normal displacement by cellular nucleophiles or enzymatic action, but is preferably caused to occur selectively as a predetermined release site by application of an external signal. The external signal may be light or photoexcitation, i.e. photolysis, or it may be ultrasound, i.e. sonolysis. Further, if the photolysis takes place in the presence of a magnetic field surrounding the release site, the release of the bioactive agent into surrounding healthy tissue is minimized.
Patent AU-667717-B2 (AU)
Title: Extrusion die assembly
Inventor: JOHNSON ROGER D
IPC: B29C48/50
Filed: 1993-06-28
Granted: 1996-04-04
Abstract: An extrusion die assembly (10), adapted to be secured to the discharge end of an extruder (14), for producing extruded products having different sizes and/or shapes from a single extruder without interrupting the operation of the extruder. The die assembly includes a block (11) having an inlet duct to receive thermoplastic material discharged from the extruder, and a pair of discharge ducts which diverge axially from the inlet duct and terminate in a pair of spaced die plates (15, 16). A cylindrical diversion valve (38) is rotatably mounted in the die assembly at the convergence of the outlet ducts and the inlet duct, with the valve having an angled passage extending therethrough for directing the flow of thermoplastic material from the inlet duct into one of the outlet ducts. The diversion valve enables thermoplastic material to be diverted from one die plate to the other without interrupting the operation of the extruder. <IMAGE>
Patent AU-671657-B2 (AU)
Title: Improvements in or relating to merchandise containers
Inventor: MONEY JULIAN DAVID KYRLE
IPC: B65D5/54
Filed: 1993-07-15
Granted: 1996-09-05
Abstract: PCT No. PCT/GB93/01489 Sec. 371 Date Sep. 24, 1993 Sec. 102(e) Date Sep. 24, 1993 PCT Filed Jul. 15, 1993 PCT Pub. No. WO94/02363 PCT Pub. Date Feb. 3, 1994.The disclosure relates to a merchandise container formed from folded flexible sheet material to provide a box form having side/end walls (10, 11) and a top closure (13), in which the top closure comprises integral flaps (17, 19) on the side/end walls which fold with respect to each other and the walls. The end walls (13-17) being pre-formed to bow inwardly such that when the side wall flaps (17a, 17b) are folded in overlapping relation to form the top closure, the end wall flaps (19) form outwardly extending triangular wings which fold downwardly against an increasing resistance until a certain downwardly inclined angle below the horizontal is reached when the end walls bow inwardly allowing the side walls to converge to relieve the resistance and create a force tending to bias the wings downwardly into engagement with the end walls to hold the wings against the end walls and the side wall flaps of the top closure in the closed condition.
Patent AU-734995-B2 (AU)
Title: Powered ride apparatus
Inventor: HARRAP NEIL HORACE
IPC: A63G9/00
Filed: 1997-10-06
Granted: 2001-06-28
Abstract: PCT No. PCT/NZ97/00131 Sec. 371 Date Sep. 20, 1999 Sec. 102(e) Date Sep. 20, 1999 PCT Filed Oct. 6, 1997 PCT Pub. No. WO98/15331 PCT Pub. Date Apr. 16, 1998A powered ride apparatus for swinging a rider attached to a craft through the air for excitement, comprises a support means such as a cable extending between at least two anchor points positioned substantially opposite each other at a height above the ground, and a swing cable suspended from the support means, and a craft adapted to carry a rider during a ride, attached to the lower end of the swing cable and comprising an on-board propulsion system comprising a motor driving a propeller and a steering system operable by the rider during the ride, enabling the rider to steer the craft during the ride as the craft swings on the swing cable.
Patent AU-671849-B2 (AU)
Title: Electromagnetic device and method for boundary layer control
Inventor: NOSENSCHUCK DANIEL M
IPC: B64C21/00
Filed: 1993-06-25
Granted: 1996-09-12
Abstract: The boundary layer of a fluid travelling in a mean-flow direction relative to a surface of a wall of a body is controlled by generating in a near-wall region of the flow a magnetic field  &upbar& B having flux lines parallel to the surface of the wall and an electric current density  &upbar& J traversing the magnetic flux lines in the fluid. An electrolyte or other conductivity-enhancing material is introduced into the flow to provide an electrical conductivity gradient in the near-wall region. The magnetic field  &upbar& B and the electric current density  &upbar& J create in the fluid a force  &upbar& Jx &upbar& B having a component normal to the surface of the wall that because of the increased conductivity gradient near the surface can stabilize or destabilize flow in the boundary layer. Numerous aspects of the fluid flow and its interaction with the body can thus be controlled. As examples, shear stress in the fluid at the wall can be decreased, with a corresponding reduction in viscous drag, the characteristics of the acoustic and pressure fields in the fluid surrounding the body can be controlled to reduce noise and fatigue, and boundary layer separation can be inhibited or induced.
Patent AU-668208-B2 (AU)
Title: 4-amino-N-(4-methyl-4-piperidinyl)-2-methoxybenzamides
Inventor: LEYSEN JOSEPHA EDUARDA MARIA F
IPC: A61P25/06
Filed: 1993-07-08
Granted: 1996-04-26
Abstract: PCT No. PCT/EP93/01993 Sec. 371 Date Jan. 6, 1995 Sec. 102(e) Date Jan. 6, 1995 PCT Filed Jan. 6, 1995 PCT Pub. No. WO94/02462 PCT Pub. Date Feb. 3, 1994.Piperidinyl substituted benzamides of formula cid addition salts thereof and the stereoisomeric forms thereof, wherein R1 is hydrogen or halo; R2 is halo; R3 is hydrogen or halo; R4 and R5 each independently are hydrogen, C1-4alkyl or haloC1-4alkyl; and the group NR4R5 may also be azido, Alk is C2-4alkanediyl; pharmaceutical compositions containing said compounds of formula (I) as active ingredient; use of said compounds as a medicine; process of preparing said compounds; compounds of formula (I) containing a radioactive isotope; process of marking 5HT2-receptor sites; and process for imaging an organ are disclosed.
Patent AU-711052-B2 (AU)
Title: 2-arylbenzazole compounds
Inventor: STEVENS MALCOLM FRANCIS GRAHAM
IPC: A61P13/02
Filed: 1996-02-28
Granted: 1999-10-07
Abstract: There are disclosed herein 2-phenylbenzazole compounds having a 3'-substituent and a 4'-NR2R6 substituent in the phenyl group where R5 and R6 are each hydrogen or alkyl, or where the $'-NR5R6 substituent is N-acyl (or N-benzoyl). There are also disclosed 2-phenylbenzazole compounds in the form of 4'-N sulphamate salts. Such compounds exhibit significant selective cytotoxic activity in respect of tumor cells and provide potentially useful chemotherapeutic agents for selective treatment of a range of cancers.
Patent AU-573402-B2 (AU)
Title: Liquid crystal cell
Inventor: CROSSLAND WILLIAM ALDEN
IPC: G02F1/141
Filed: 1985-11-13
Granted: 1988-06-09
Abstract: Bistable operation of ferroelectric liquid crystal smectic 1<sup>*</sup> or smectic F* cells is disclosed which uses a greater liquid crystal layer thickness than is achievable with smectic C* material while yet retaining bistability of operation. One or more such cells are employed in two-dimensional information processing apparatus.
Patent AU-706604-B2 (AU)
Title: Method of multiplexing/demultiplexing analog signals and datastream
Inventor: MESTDAGH DENIS JULIEN GILLES
IPC: H04M11/06
Filed: 1996-04-15
Granted: 1999-06-17
Abstract: An analog MTS (Message Telephone Service) signal (TS) and an ADSL (Asymmetric Digital Subscriber Line) datastream (AD) are multiplexed to be transmitted simultaneously on a twisted pair transmission line (TL). In a first step, the analog MTS (Message Telephone Service) signal (TS) is transformed into a digital form (DS, TSC). The digital MTS (Message Telephone Service) signal (DS, TSC) in a second step is embedded in the ADSL (Asymmetric Digital Subscriber Line) datastream (AD). At the receiver side, the digital MTS (Message Telephone Service) signal (DS, TSC) and ADSL (Asymmetric Digital Subscriber Line Service) datastream (AD) are split up again, and the digital MTS (Message Telephone Service) signal (DS, TSC) is retransformed into the analog MTS (Message Telephone Service) signal (TS). To maintain telephone service even when the ADSL equipment fails, an alternative path enables transmission of the MTS (Message Telephone Service) signal in its analog form, independently from the ADSL equipment. <IMAGE>
Patent AU-739058-B2 (AU)
Title: Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens
Inventor: ANDERSON DARRELL R
IPC: A61K38/00
Filed: 1997-10-29
Granted: 2001-10-04
Abstract: The present invention relates to the identification of antibodies which are specific to human B7.1 antigen (CD80) and which are capable of inhibiting the binding of B7.1 to a CD28 receptor and which are not capable of inhibiting the binding of B7.1 to a CTLA-4 receptor. Two of these antibodies, 16C10 and 7C10, significantly inhibit the production of IL-2, in spite of the existence of a second activating ligand B7.2 (CD86). Blocking of the primary activation signal between CD28 and B7.1 (CD80) with these antibodies while allowing the unimpaired or coincident interaction of CTLA-4 and B7.1 and/or B7.2 represents a combined antagonistic effect on positive co-stimulation with an agonistic effect on negative signalling. These antibodies may be used as specific immunosuppressants, e.g., for the treatment of autoimmune diseases and to prevent organ transplant rejection.
Patent AU-582814-B2 (AU)
Title: Apparatus for effecting gas-liquid contact
Inventor: BRATTAN KEITH
IPC: B01D1/14
Filed: 1986-01-10
Granted: 1989-04-13
Abstract: An apparatus for effecting direct contact between a gas and a liquid which comprises at least one substantially vertical channel, formed for example, by a pair of parallel plates. means for introducing gas at a lower part of the channel. means for introducing liquid to the channel, and means for removing gas and liquid at an upper part of the channel, the height of the channel being substantially greater than the distance between the walls thereof which define the channel, e.g. between the parallel plates, such that gas at elevated pressure, when introduced into the channel, can cause liquid to move upwardly in the channel and to be removed from the channel. The apparatus may be associated with an electrolytic cell in which a gas is produced by electrolysis. Also a process for effecting direct contact between a gas and a liqud.
Patent AU-709576-B2 (AU)
Title: Flat-folded personal respiratory protection devices and processes for preparing same
Inventor: BOSTOCK GRAHAM J
IPC: A62B7/10
Filed: 1996-03-08
Granted: 1999-09-02
Abstract: Fold-flat personal respiratory protection devices are provided. The devices have a flat central portion having first and second edges, a flat first member joined to the first edge of the central portion through either a fold-line, seam, weld or bond, said fold, bond, weld or seam of the first member being substantially coextensive with said first edge of said central portion, and a flat second member joined to the second edge of the central portion through either a fold-line, seam, weld or bond, the fold, bond, weld or seam of the second member being substantially coextensive with said second edge of said central portion. At least one of the central portion and first and second members are formed from filter media. The device is capable of being folded flat for storage with the first and second members being in at least partial face-to-face contact with a common surface of the central portion and, during use, is capable of forming a cup-shaped air chamber over the nose and mouth of the wearer with the unjoined edges of the central portion and first and second members adapted to contact and be secured to the nose, cheeks and chin of the wearer. The outer boundary of the unjoined edges which are adapted to contact the nose, cheeks and chin of the wearer are less than the perimeter of the device in the flat folded storage state. Also provided are processes for preparing such devices.
Patent AU-672066-B2 (AU)
Title: Cell buffer memory management
Inventor: HENRION MICHEL
IPC: G06F13/38
Filed: 1994-01-18
Granted: 1996-09-19
Abstract: This device receives several cell streams characterised by different cell loss rate performances and comprises means for recognising that a cell loss is inevitable when the buffer memory is full, as well as means for deciding that an incoming cell should be recorded in the buffer memory instead of another cell which will be lost. It furthermore comprises means (CF1..., CFi..., CFn) for associating with each cell stream (FC1..., FCi..., FCn) a dynamic indication of cell loss balance (CLF1..., CLFi..., CLFn), which is a function of a cell loss performance (Ni) allotted to this stream and cell losses (RTi) actually noted for this cell stream, and means (SCDA) for selecting a cell stream, especially by comparing the said dynamic indications of cell loss, and for causing as a consequence the incoming cell to be recorded in the buffer memory instead of a cell of the selected cell stream. <IMAGE>
Patent AU-770595-B2 (AU)
Title: Hollow microneedle patch
Inventor: WHITSON ROBERT C
IPC: G01N21/78
Filed: 2001-06-22
Granted: 2004-02-26
Abstract: A test strip is provided for use in the determination of the concentration of an a chemical in blood. The test strip comprises a plurality of microneedles and a test area. Each microneedle is adapted to puncture skin and to draw blood. The test area is in fluid communication with the microneedles. The test area contains a reagent adapted to produce a reaction indicative of the concentration of the chemical in blood.
Patent AU-738283-B2 (AU)
Title: Aqueous herbicide/surfactant compositions for basal or dormant stem brush control
Inventor: RIEGO DOMINGO C
IPC: A01N25/30
Filed: 1998-02-12
Granted: 2001-09-13
Abstract: An aqueous herbicidal composition is provided which is useful for controlling woody plants when applied to bark in basal and dormant stem regions of such plants. The composition is an aqueous solution or dispersion of a water-soluble herbicide such as a salt of glyphosate and a surfactant composition, which comprises one or more polyoxyalkylene trisiloxane surfactant(s) and one or more glycols or glycol ethers. Also provided is a method for controlling woody plants comprising applying to bark in basal or dormant stem regions of such plants an aqueous herbicidal composition of the invention.